The JCA-Mauvernay Award / Japan

The JCA-Mauvernay Award is organised each year in collaboration with the Japan Cancer Association (JCA). This award has a total value of CHF 25'000 ant it aims at recognising outstanding achievements in the field of oncology amongst Japanese researchers.

The Award, funded by Debiopharm and organised by the JCA, aims at recognising cutting-edge oncology research in both the fundamental and the clinical aspects and to encourage Japanese researchers to make their work available to other parts of the world. Potential Candidates must be researchers and members of the JCA who have been recommended by the councillors of the JCA and who have achieved excellent results in the fields of either basic or clinical research in oncology. The JCA counts about 17'000 members, all from universities, governmental and private research organisations throughout Japan.

Each year, the Award Committee selects nominee(s) for the JCA-Mauvernay Award from fundamental cancer research and/or clinical cancer research.

The 2011 JCA-Mauvernay Award was granted on October 5, 2011 during the 70th Annual Meeting of the Japan Cancer Association held at the Nagoya Congress Center in Nagoya, Japan.

Awardees:

2011

• Doctor Hirofumi Arakawa from the National Cancer Center Research Institute in Tokyo
• Doctor Mineo Kurokawa from the University of Tokyo

2010

• Doctor Seishi Ogawa from the University of Tokyo
• Professor Shin Maeda from Yokohama City University of Medicine

The Japanese Cancer Association and Debiopharm Group™ present the JCA-Mauvernay Award to Dr Ogawa and Prof. Maeda for their outstanding oncology research

2009

• Dr Toshikazu Ushijima, National Cancer Center Research Institute, Tokyo

The Japanese Cancer Association and Debiopharm Group present the JCA-Mauvernay Award to Dr Ushijima for his oncology research

2008

• Professor Hidenori Ichijo, Graduate School of Pharmaceutical Sciences, University of Tokyo
• Professor Hiroyuki Mano, Functional Genomics Division at Jichi Medical University

Japanese Cancer Association and Debiopharm Honour Japanese Research - Professors Ichijo and Mano receive 2008 JCA-Mauvernay Award

2007

• Professor Minoru Toyota, First Department of Internal Medicine, Sapporo Medical University,
• Professor Keiichi Nakayama, Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University

Japanese Scientists Receive JCA-Mauvernay Award 2007

2006

• Professor Hatakeyama, Institute for Genetic Medecine, Hokkaido University
• Professor Inazawa, Medical Research Institute, Tokyo Medical & Dental University

• Dr Mitsudomi, Aichi Cancer Center Hospital
• Dr Ishikawa, Graduate School of Biostudies, Kyoto University